Technetium-99m sestamibi scintigraphy (99mTc-MIBI) predicts head and neck squamous cell carcinoma (SCCA) response to radiochemotherapy
Christian Gläser(University Clinic of Traumatology), Robert S. Lavey(Moffitt Cancer Center), Edgar Selzer(Vienna General Hospital), W. Millesi(Vienna General Hospital), Thomas Leitha(Vienna General Hospital), Rolf Ewers(Vienna General Hospital), Stefan Lang(Friedrich-Alexander-Universität Erlangen-Nürnberg), Earl H. Leonard(Children's Hospital of Los Angeles)
International Journal of Radiation Oncology*Biology*Physics
January 1, 2000
Cited by 0
Related Papers
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV
|Radiotherapy and Oncology|2005|1.6k
Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer
|Radiotherapy and Oncology|2007|541
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group
|Neuro-Oncology|2011|342
The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results
|International Journal of Radiation Oncology*Biology*Physics|2006|322
Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer
|International Journal of Radiation Oncology*Biology*Physics|2005|313